Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)

被引：1
|
作者：
Papadaki, M. A. [1 ]
Kapetanaki, E-E. [1 ]
Vorrias, E. [2 ]
Mavroudis, D. [3 ]
Agelaki, S. [3 ]
机构：
[1] UOC Univ Crete, Lab Translat Oncol, Sch Med, Iraklion, Greece
[2] Univ Gen Hosp Herakl, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Univ Gen Hosp Heraklion, Sch Med, Dept Med Oncol,Lab Translat Oncol, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1653P
引用
收藏
页码：S1166 / S1166
页数：1
相关论文
共 50 条
  • [21] Differential expression of PD-L1 on circulating tumor cells among patients with advanced lung cancer
    Kim, Woong
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Yagi, Satomi
    Tanaka, Ayaka
    Kanai, Kuninobu
    Hayata, Atsushi
    Shibaki, Ryota
    Higuchi, Masayuki
    Kanbara, Hisashige
    Kikuchi, Takashi
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. CANCER RESEARCH, 2016, 76
  • [22] PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion
    Tseng, Yen-Han
    Ho, Hsiang-Ling
    Lai, Chiung-Ru
    Luo, Yung-Hung
    Tseng, Yen-Chiang
    Whang-Peng, Jacqueline
    Lin, Yi-Hsuan
    Chou, Teh-Ying
    Chen, Yuh-Min
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : 447 - 453
  • [23] PD-L1 Expression in Circulating Tumor Cells and Response to PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer Patients
    Guibert, N.
    Delaunay, M.
    Boubekeur, N.
    Rouquette, I.
    Lusque, A.
    Clermont, E.
    Fortoul, A.
    Farella, M.
    Favre, G.
    Pradines, A.
    Mazieres, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1997 - S1997
  • [24] Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Ikeda, Mio
    Koh, Yasuhiro
    Teraoka, Shunsuke
    Sato, Koichi
    Oyanagi, Jun
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. CANCERS, 2021, 13 (10)
  • [25] Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
    Kallergi, Galatea
    Vetsika, Eleni-Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Messaritakis, Ippokratis
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [26] Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non-Small Cell Lung Cancer
    Song, Peng
    Guo, Lei
    Li, Wenbin
    Zhang, Fan
    Ying, Jianming
    Gao, Shugeng
    [J]. JOURNAL OF IMMUNOTHERAPY, 2019, 42 (01) : 23 - 28
  • [27] Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)
    Bergmann, Sonja
    Coym, Anja
    Ott, Leonie
    Soave, Armin
    Rink, Michael
    Janning, Melanie
    Stoupiec, Malgorzata
    Coith, Cornelia
    Peine, Sven
    von Amsberg, Gunhild
    Pantel, Klaus
    Riethdorf, Sabine
    [J]. ONCOIMMUNOLOGY, 2020, 9 (01):
  • [28] Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder
    Bergmann, Sonja
    Coym, Anja
    von Amsberg, Gunhild
    Janning, Melanie
    Soave, Armin
    Rink, Michael
    Pantel, Klaus
    Riethdorf, Sabine
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [29] PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Pantazaka, Evangelia
    Ntzifa, Aliki
    Roumeliotou, Argyro
    Lianidou, Evi
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Kallergi, Galatea
    [J]. BIOMEDICINES, 2022, 10 (08)
  • [30] EVALUATION OF CIRCULATING TUMOUR CELLS (CTCS) IN SMALL CELL LUNG CANCER (SCLC) PATIENTS UNDERGOING CHEMOTHERAPY
    Hou, J.
    Greystoke, A.
    Williamson, A.
    Lancashire, L.
    Ashcroft, L. F.
    Lorigan, P.
    Hughes, S.
    Dive, C.
    Blackhall, F. H.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 252 - 252
12345